Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 276,506 shares at $10.40 ($2.9M) on 2018-01-22, disclosed to the SEC on 2018-01-24.
Open-market sale of $2.9M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.40 | 138,253 | $1.4M | 50.0% |
| 2 | $10.40 | 138,253 | $1.4M | 50.0% |
| Total | $10.40 avg | 276,506 | $2.9M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |